186 related articles for article (PubMed ID: 24461891)
1. Changing perceptions in pulmonary hypertension.
Gerges C; Lang IM
Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
[No Abstract] [Full Text] [Related]
2. Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Burger CD
Ann Am Thorac Soc; 2015 Jun; 12(6):959. PubMed ID: 26075561
[No Abstract] [Full Text] [Related]
3. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Jun; 12(6):960. PubMed ID: 26075562
[No Abstract] [Full Text] [Related]
4. [Targeted therapy of pulmonary arterial hypertension (PAH)].
Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
[No Abstract] [Full Text] [Related]
5. Macitentan for the treatment of pulmonary arterial hypertension.
DuBrock HM; Channick RN
Expert Rev Respir Med; 2014 Aug; 8(4):393-9. PubMed ID: 24998329
[TBL] [Abstract][Full Text] [Related]
6. Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Feb; 12(2):269-73. PubMed ID: 25590376
[TBL] [Abstract][Full Text] [Related]
7. [Pulmonary hypertension].
Kovacs G; Olschewski H
Dtsch Med Wochenschr; 2012 Oct; 137(40):2026-8. PubMed ID: 23023615
[No Abstract] [Full Text] [Related]
8. [Systemic sclerosis - an update].
Bergmann C; Distler JH
Dtsch Med Wochenschr; 2015 Apr; 140(7):504-7. PubMed ID: 25826034
[No Abstract] [Full Text] [Related]
9. Riociguat recommended by CHMP for approval in the EU for use in two forms of pulmonary hypertension.
Dowdall M
Future Cardiol; 2014 Mar; 10(2):163. PubMed ID: 24883440
[No Abstract] [Full Text] [Related]
10. [The SERAPHIN study].
D'Alto M; Vitulo P
G Ital Cardiol (Rome); 2015 Jan; 16(1):6-10. PubMed ID: 25689745
[No Abstract] [Full Text] [Related]
11. Efficacy of pulmonary vasodilator therapy in patients with functionally single ventricle.
Park IS
Int Heart J; 2015; 56 Suppl():S26-30. PubMed ID: 25787795
[TBL] [Abstract][Full Text] [Related]
12. Riociguat, an oral soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.
Belik J
Curr Opin Investig Drugs; 2009 Sep; 10(9):971-9. PubMed ID: 19705340
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary pulmonary hypertension -- the next generation.
Newman JH
N Engl J Med; 2002 Mar; 346(12):933-5. PubMed ID: 11907295
[No Abstract] [Full Text] [Related]
14. Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension.
Langleben D
Clin Chest Med; 2007 Mar; 28(1):117-25, viii. PubMed ID: 17338931
[TBL] [Abstract][Full Text] [Related]
15. What is new about Rio?
Souza R; Kawut SM
Eur Respir J; 2015 May; 45(5):1211-3. PubMed ID: 25931483
[No Abstract] [Full Text] [Related]
16. [Blockade of endothelin receptor with bosentan--a new principle of treatment in pulmonary arterial hypertension].
Nielsen-Kudsk JE
Ugeskr Laeger; 2003 Jul; 165(29):2891-4. PubMed ID: 12908360
[TBL] [Abstract][Full Text] [Related]
17. Medical Therapy in Chronic Thromboembolic Pulmonary Hypertension.
Pepke-Zaba J; Jais X; Channick R
Ann Am Thorac Soc; 2016 Jul; 13 Suppl 3():S248-54. PubMed ID: 27571006
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-receptor antagonism: the future is bright.
Dhaun N; Webb DJ
Lancet; 2008 Jun; 371(9630):2061-2. PubMed ID: 18572063
[No Abstract] [Full Text] [Related]
19. [Endothelin receptor blockers--one more agent for the treatment of pulmonary hypertension].
Minushkina LO; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(9):67-71. PubMed ID: 14593372
[TBL] [Abstract][Full Text] [Related]
20. Macitentan for the treatment of pulmonary arterial hypertension.
Kholdani CA; Fares WH; Trow TK
Vasc Health Risk Manag; 2014; 10():665-73. PubMed ID: 25473292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
